Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence

BACKGROUND: Although antibodies blocking immune checkpoints have already been approved for clinical cancer treatment, the mechanisms involved are not yet completely elucidated. Here we used a λ-MYC transgenic model of endogenously growing B-cell lymphoma to analyze the requirements for effective the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunother Cancer
Main Authors: Ahmetlic, Fatima, Fauser, Josia, Riedel, Tanja, Bauer, Vera, Flessner, Carolin, Hömberg, Nadine, Hennel, Roman, Brenner, Ellen, Lauber, Kirsten, Röcken, Martin, Mocikat, Ralph
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2021
Teme:
Basic Tumor Immunology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812096/
https://ncbi.nlm.nih.gov/pubmed/33441389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001660
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki